Zobrazeno 1 - 10
of 103
pro vyhledávání: '"J E, Lowe"'
Autor:
Karolina Kozak Bidzinski, Darby J. E. Lowe, Marcos Sanches, Maryam Sorkhou, Isabelle Boileau, Michael Kiang, Daniel M. Blumberger, Gary Remington, Clement Ma, David J. Castle, Rachel A. Rabin, Tony P. George
Publikováno v:
npj Schizophrenia, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Cannabis use disorder (CUD) occurs at high rates in schizophrenia, which negatively impacts its clinical prognosis. These patients have greater difficulty quitting cannabis which may reflect putative deficits in the dorsolateral prefrontal c
Externí odkaz:
https://doaj.org/article/616ddf90cca246e7bfc1efc072f8aad3
Autor:
Samantha Johnstone, Maryam Sorkhou, Nada Al-Saghir, Darby J. E. Lowe, Vaughn R. Steele, Godfrey D. Pearlson, David J. Castle, Tony P. George
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundSubstance use disorders (SUDs) are a common yet poorly studied comorbidity in individuals with psychotic disorders. The co-occurrence of the two complicates recovery and interferes with pharmacological and behavioral treatment response and
Externí odkaz:
https://doaj.org/article/8b1f69474f544bfc87aa0b4f17ec0032
Publikováno v:
Frontiers in Psychiatry, Vol 9 (2018)
Purpose of review: To provide an overview of the underlying neurobiology of tobacco smoking in schizophrenia, and implications for treatment of this comorbidity.Recent findings: Explanations for heavy tobacco smoking in schizophrenia include pro-cogn
Externí odkaz:
https://doaj.org/article/a009460e3f994fc499191a87200c1490
Autor:
Darby J. E. Lowe, Philip H. Smith, Rachel A. Rabin, Tony P. George, Karolina Kozak, Andrea H. Weinberger, Ziva D. Cooper
Publikováno v:
Am J Drug Alcohol Abuse
BACKGROUND: While males are more likely diagnosed with cannabis use disorder (CUD), females are more susceptible to developing and maintaining CUD. Yet, for both sexes, CUD is associated with high rates of comorbid mental illness (MI). OBJECTIVES: To
Autor:
Samantha Johnstone, Darby J. E. Lowe, Karolina Kozak-Bidzinski, Marcos Sanches, David J. Castle, Jennifer S. Rabin, Rachel A. Rabin, Tony P. George
Publikováno v:
Schizophrenia (Heidelberg, Germany). 8(1)
Repetitive transcranial magnetic stimulation (rTMS) is a promising treatment for cannabis use disorder in schizophrenia; however, gaps in the literature remain as to the potential role of neurocognitive functioning in treatment response. We evaluated
Autor:
Karolina Kozak Bidzinski, Darby J. E. Lowe, Marcos Sanches, Maryam Sorkhou, Isabelle Boileau, Michael Kiang, Daniel M. Blumberger, Gary Remington, Clement Ma, David J. Castle, Rachel A. Rabin, Tony P. George
Publikováno v:
Schizophrenia (Heidelberg, Germany). 8(1)
Cannabis use disorder (CUD) occurs at high rates in schizophrenia, which negatively impacts its clinical prognosis. These patients have greater difficulty quitting cannabis which may reflect putative deficits in the dorsolateral prefrontal cortex (DL
Publikováno v:
The American Journal on Addictions. 28:503-511
Background and objectives Patients with schizophrenia have higher rates of tobacco smoking compared to the general population. Moreover, these patients have deficits in cognition, including verbal learning and memory. However, it is not clear whether
With the increasing push to legalize cannabis in Western nations, there is a need to gage the potential impact of this policy change on vulnerable populations, such as those with mental illness, including schizophrenia, mood, and anxiety disorders. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd40647ee135879faeab5f9f44080b2
https://europepmc.org/articles/PMC6397076/
https://europepmc.org/articles/PMC6397076/
Publikováno v:
Diabetes. 45:183-189
Publikováno v:
Methods in molecular medicine. 38
A large number of studies indicate that DNA damage and mutation increase with age in human cells and tissues (1). Age-related degenerative disorders in which DNA damage has been invoked include heart disease and neurodegenerative conditions such as A